MARC Record from bcl_marc

LEADER: 11285cam 2200577 a 4500
005 20071019152926.0
008 060810s2007 enka bf 001 0 eng
010 $a2007279820
015 $aGBA671659$2bnb
016 7 $a101307709$2DNLM
016 7 $a013536566$2Uk
020 $a9780198569244 (flexicover : alk. paper)
020 $a0198569246 (flexicover : alk. paper)
035 $a(OCoLC)ocm71163790
040 $aNLM$cNLM$dUKM$dBAKER$dBWKUK$dYDXCP$dIXA$dBTCTA$dNLGGC$dDLC$dNOR
042 $aukblcatcopy$anlmcopyc
049 $aBXMM
050 00 $aRC266$b.O94 2007
060 00 $a2007 G-307
060 10 $aWY 49$bO97 2007
082 04 $a616.9940231$222
084 $a44.63$2bcl
245 00 $aOxford handbook of cancer nursing /$cedited by Mike Tadman, Dave Roberts.
246 3 $aHandbook of cancer nursing
260 $aOxford ;$aNew York :$bOxford University Press,$c2007.
300 $axxviii, 693 p. :$bill. ;$c19 cm.
440 0 $aOxford handbooks in nursing
504 $aIncludes bibliographical references and index.
505 00 $tContributors --$tAbbreviations --$tDedications --$tSection 1 : Introduction --$g1.$tIntroduction --$tScientific advances --$tPolicy initiatives --$tClinical implications --$tSpecialist nursing roles --$gThe$trole of the patient in cancer care --$gThe$tmultidisciplinary team --$gThe$tNational Institute for Health and Clinical Excellence (NICE) --$tSection 2 : The cancer problem --$g2.$tCancer epidemiology --$gThe$tcancer problem --$tUK situation --$tUK mortality --$tSurvival --$tAetiology --$g3.$tCancer biology --$tIntroduction --$tDifferences between normal cells and cancer cells --$tOncogenes and tumour suppressor genes (TSGs) --$tTumour growth --$tMetastasis (spread of secondary tumour) --$tImmunology --$tTumour classification --$g4.$tCancer prevention and screening --$tCancer prevention --$tCancer screening --$tScreening recruitment --$tBreast cancer screening --$tCervical cancer screening --$tBowel and prostate cancer screening --$tDietary prevention --$tSmoking cessation --$tSkin cancer prevention --$tCancer genetics --$tCommon cancers with inherited predisposition --
505 00 $tSection 3 : The experience of cancer --$g5. The$tpersonal experience of cancer --$tIntroduction --$gThe$tcancer journey --$tCalendars --$tDiagnosis --$tReactions to diagnosis and treatment --$tLiving with cancer --$tFear of recurrence --$tRecurrence and facing death --$tSurvivorship --$g6. The$tsocial experience of cancer --$gThe$tfamily experience of cancer --$tChildren and families --$tEmployment and finances --$tCulture and the meaning of cancer --$tGender, age, and cancer --$tEthnicity and cancer --$tThreats to personal identity --$tSection 4 : Supportive and palliative care --$g7.$tSupportive care --$tBackground --$tCommunication in cancer care --$tPromoting effective communication --$tImparting significant news (breaking bad news) --$g8.$tInformation and user involvement --$tInformation --$tPatient and family involvement in decision-making --$tpatient involvement in evaluating and managing health care --$g9.$tPsychological, social, and spiritual support --$tTherapeutic relationships with people with cancer --$tPsychological support --$tSpecific psychological interventions --$tSocial support --$tSpiritual support and chaplaincy --$g10.$tRehabilitation of the cancer patient --$tRehabilitation of the cancer patient --
505 00 $g11.$tComplementary therapies --$tComplementary therapies --$tRegulation and training --$g12.$tPalliative care --$tBackground --$tInterface between cancer and palliative care services --$tCaring for dying people --$tBereavement --$tModels of bereavement --$tSupport for the bereaved --$g13.$tEthics in cancer care --$tIntroduction and overview of ethical guidance --$tEnd of life issues --$tWithdrawing and withholding treatment --$tSection 5 : Clinical management of cancer --$g14.$tDiagnosis and staging --$tDiagnosis, classification, and staging of cancer --$tPatient assessment --$tRadiological imaging --$tStaging and grading cancer --$g15.$tSurgery and cancer --$tCancer surgery --$tPreparing patients for cancer surgery --$tPerioperative care of patients --$g16.$tRadiotherapy --$tPrinciples and uses --$tTreatment modalities --$tTreatment planning and delivery --$tManagement of radiotherapy treatment and its side effects --$tSkin toxicity --$g17.$tChemotherapy --$tPrinciples and uses --$tChemotherapy regimens --$tSafe handling --$tSafe administration --$tRoutes of administration --$tOral chemotherapy --$tAdministering vesicants and extravasation --$tSide effects and complications --$tChemotherapy in the home setting --$tNew approaches in chemotherapy treatment --
505 00 $g18.$tHormonal therapy --$tBackground --$tAssessment and management of side effects --$g19.$tBiological therapy --$tPrinciples --$tImmunotherapy --$tMonoclonal antibodies --$tOther biological therapies --$g20.$tHigh dose therapy (autologus transplant) --$tPrinciples and uses --$tConditioning --$tNursing issues of high dose therapy --$g21.$tAllogeneic haemopoietic stem cell transplantation --$tPrinciples --$tComplications of allogeneic transplant --$tReduced intensity conditioning (RIC) transplants --$g22.$tClinical trials --$tClinical trials in the cancer setting --$tPhases of clinical trials --$tNurses' responsibilities --$tVulnerable patients --$tSection 6 : Management of major cancers --$g23.$tBone cancer --$tBone sarcomas --$tSoft tissue sarcomas --$tSurgical treatments --$tMetastatic bond disease (MBD) --$g24.$tBreast cancer --$tIntroduction --$tDiagnosis and staging --$tManagement of non-invasive breast cancer --$tManagement of early breast cancer --$tAdjuvant treatment of early breast cancer --$tManagement of locally advanced breast cancer --$tManagement of metastatic breast cancer --$tBreast reconstruction --$tNursing management issues --
505 00 $g25.$tCentral nervous system cancer --$tIntroduction --$tClassification of primary CNS tumours --$tManagement of primary CNS malignancy --$tMetastatic brain disease --$tNursing management issues --$g26.$tColorectal cancer --$tIntroduction --$tTreatment approaches to colorectal cancer --$tCare of the patient with a stoma --$tNursing management issues --$g27.$tCancer of unknown primary (CUP) --$tIntroduction and prognosis --$tTreatment and nursing management --$g28.$tEndocrine cancers --$tIntroduction and types of endocrine cancers --$g29.$tUpper gastrointestinal cancers --$tIntroduction --$tOesophageal cancer --$tGastric cancer --$tSmall intestine and carcinoid tumours --$tCancer of the liver (Hepatocellular cancer) --$tCancer of the gall bladder and bile ducts --$tPancreatic cancer --$tNursing management issues --$g30.$tGenitourinary cancers --$tRenal cancer --$tCancer of the bladder and ureter --$tProstate cancer --$tTesticular cancer --$tPenile cancer --$tNursing management issues --
505 00 $g31.$tGynaecological cancers --$tIntroduction --$tOvarian cancer --$tCancer of the cervix --$tEndometrial cancer --$tVulval and vaginal cancer --$tNursing management issues --$g32.$tHaematological cancers --$tIntroduction --$tAcute leukaemia --$tChronic leukaemia --$tHodgkin's lymphoma (Hodgkin's disease) --$tNon-Hodgkin's lymphoma (NHL) --$tMyeloma --$g33.$tHead and neck cancers --$tIntroduction --$tTreatment of head and neck cancer --$tLaryngectomy and tracheostomy --$tNursing management issues --$g34.$tHIV related cancer --$tHIV related malignancies --$tNursing management issues --$g35.$tLung cancer --$tIntroduction --$tManagement of non-small cell lung cancer (NSCLC) --$tManagement of small cell lung cancer (SCLC) --$tMesothelioma --$tNursing management issues --$g36.$tSkin cancer --$tMalignant melanoma --$tNon-melanoma skin cancer --
505 00 $tSection 7 : Symptom management --$g37.$tAssessment --$tIntroduction --$tProcess of assessment --$tAssessment tools --$tQuality of life (QoL) --$tDimensions of QoL --$tQoL in practice --$g38.$tBone marrow suppression --$tBone marrow function --$tAnaemia --$tNeutropaenia --$tTreatment of febrile neutropaenia and sepsis/septic shock --$tBleeding --$tBleeding in advanced cancer --$g39.$tBlood product support --$tblood products --$gThe$tnurse's role in blood product transfusions --$g40.$tThrombosis --$tVenous thrombosis --$g41.$tAltered bowel function --$tDiarrhoea --$tConstipation --$tBowel obstruction --$g42.$tCancer-related breathlessness --$tCauses, diagnosis, and assessment --$tManagement --$g43.$tCancer-related fatigue --$tCauses and assessment --$tManagement --$g44.$tMalignant effusions --$tIntroduction --$tMalignant pleural effusion --$g45.$tNausea and vomiting --$tTreatment-related nausea and vomiting (ANV) --$tNausea and vomiting in advanced cancer --$g46.$tNutritional disorders --$tNutritional issues --$tNutritional support --$tSupport of specific nutritional complications --
505 00 $g47.$tPain management --$tIntroduction --$tPain assessment --$tPrinciples of analgesic use --$tClassification of pain --$tUse of opioid drugs --$tUse of syringe drivers in pain control --$tNon-pharmacological interventions for pain management --$g48.$tSymptoms management at the end of life --$tIntroduction --$tNoisy breathing : 'death rattle' --$tTerminal agitation --$g49.$tPsychological reactions to cancer --$tIntroduction --$tAdjustment, stress reactions, and disorders --$tSupporting the cancer patient through periods of adjustment --$tPsychological assessment --$tDepression --$tSuicide and suicidal ideas --$tTreatment of depression --$tAnxiety --$tAnxiety management --$tPharmacological treatment of anxieity --$tAssessment and support of the anxious patient --$g50.$tOther psychological problems encountered in people with cancer --$tAccute confusional states --$tPsychoses and their management --$tViolence and aggression --$tAlcohol misuse --$tNursing management of people who are alcohol dependent --$g51.$tAltered body image --$tIntroduction --$tAssessment and support --
505 00 $g52.$tSexual health and cancer --$tIntroduction --$tAssessment and communication about sexual health --$g53.$tSkin and mucosal alterations --$tHair loss (alopecia) --$tScalp cooling (scalp hypothermia) --$tOral mucositis and related problems --$tOral mucositis : managing the process and symptoms --$tOesophagitis --$tOral care in advanced cancer --$tMalignant wounds --$tLymphoedema --$tSection 8 : Oncological emergencies --$g54.$tOncological emergencies --$tAnaphylaxis --$tDisseminated intravascular coagulation --$tMalignancy induced hypercalcaemia --$tSpinal cord compression --$tSuperior vena cava obstruction --$tSyndrome of inappropriate antidiuretic hormone --$tTumour lysis syndrome --$tUseful websites --$tIndex.
650 0 $aCancer$xNursing.
650 2 $aNeoplasms$xnursing$vHandbooks.$2[MeSH]
650 2 $aNeoplasms$vHandbooks.$2[MeSH]
700 1 $aTadman, Mike.
700 1 $aRoberts, Dave,$cMSc.
852 0 $bONL$cSTACK$hRC266$i.O94 2007
948 $aLTI 10/26/2007
994 $aC0$bBXM
029 0 $aNLM$b101307709
029 1 $aYDXCP$b100448694
029 1 $aNLGGC$b302299513
938 $aYBP Library Services$bYANK$n100448694
938 $aBaker & Taylor$bBKTY$c39.95$d.00$i0198569246$n0006923358$sactive
938 $aBaker and Taylor$bBTCP$nBK0006923358